ArticleAfrican journal of laboratory medicine2026
Impaired clinical, biological, and cytokine patterns in HIV-1 exposed uninfected newborns in Yaoundé: A comparative study of neonatal immune vulnerability.
Article in African journal of laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immune dysregulation is hypothesised to underpin the heightened susceptibility of HIV-1-exposed uninfected (HEU) infants to morbidity and mortality, which occurs at a rate three times higher than that of HIV-1-unexposed uninfected (HUU) controls. However, robust evidence substantiating this hypothesis and advocating targeted interventions remains scarce in Cameroon. Objective: To examine how maternal HIV-1 infection influences the immune response of HEU neonates in Yaoundé. Methods: A comparative cross-sectional study was conducted in 280 mother-child pairs at birth in Yaoundé. Clinical parameters were assessed, while umbilical cord blood samples from both HEU and HUU newborns were analysed for comprehensive immunophenotyping and quantification of 12 pro-inflammatory and anti-inflammatory cytokines. Results: Significant differences were observed between HEU (representing 100% of exposed newborns tested) and HUU newborns. Notably, 1/54 (1.85%) of HEU newborns exhibited a lower Appearance, Pulse, Grimace, Activity, Respiration score at 1 min ( Conclusion: Maternal HIV-1 infection is associated with impaired outcomes in HEU newborns, highlighted by immune dysregulation in an early pro-inflammatory environment. These findings underscore the heightened vulnerability of HEU neonates and elucidates the underlying factors contributing to their subsequent health challenges. What this study adds: It provides initial information on pertinent but not yet described pro-inflammatory cytokines impairment in Cameroonian HEU newborns. Unlike previous research that has focused on their KIR-21 gene expression and responsiveness to measles vaccine, this study introduces their immunological responses through their umbilical cord blood analysis, a previously unexamined specimen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.